Patient-derived Models: A Promising Frontier in Testing the Efficacy of Drugs for Bladder Cancer

IF 25.3 1区医学 Q1 UROLOGY & NEPHROLOGY

European urology Pub Date : 2024-11-01 DOI:10.1016/j.eururo.2024.08.020

Henning Plage , Franz F. Dressler , Annika Fendler

引用次数: 0

查看原文本刊更多论文

患者衍生模型：测试膀胱癌药物疗效的前景光明的前沿。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European urology 医学-泌尿学与肾脏学

CiteScore

43.00

自引率

2.60%

发文量

1753

审稿时长

23 days

期刊介绍： European Urology is a peer-reviewed journal that publishes original articles and reviews on a broad spectrum of urological issues. Covering topics such as oncology, impotence, infertility, pediatrics, lithiasis and endourology, the journal also highlights recent advances in techniques, instrumentation, surgery, and pediatric urology. This comprehensive approach provides readers with an in-depth guide to international developments in urology.